Pharmacists in Kemah, TX Accepting Medicare
4 Pharmacists found. Showing 1 - 4
 Mr. Parthiv Waghwala, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 156 Fm 518 Rd, Kemah, TX 77565 Phone: 281-538-3989 |
 Veronica Estela Reddington, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 255 Fm 518 Rd, Kemah, TX 77565 Phone: 281-538-9978 |
Hanan Khaled Loubani Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 255 Fm 518 Rd, Kemah, TX 77565 Phone: 281-538-9978 |
Linh Ngoc Lieu, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 255 Fm 518 Rd, Kemah, TX 77565 Phone: 281-538-9978 Fax: 281-538-1889 |
News Archive
First Edition: April 8, 2014
Kaiser Health News staff writer Jay Hancock reports: "Under intense, bipartisan political pressure, the Obama administration backed down for the second year in a row on proposed payment cuts for insurance companies that offer private plans to Medicare members.
FDA approves Biologics' IMBRUVICA as oral agent for treatment of patients with CLL
Biologics, a limited distribution network partner for IMBRUVICA™ (ibrutinib), is pleased to announce the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™ (ibrutinib) capsules as a single, oral agent for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
Advanced Biventricular Pacemakers to all patients with AV-block?
World Congress of Cardiology Report - Pacemaker treatment for bradycardia is frequently used with more than 500,000 people worldwide receiving a cardiac pacemaker each year.
Rosa/KressWorks Foundation completes first milestone in development of Ewing's sarcoma PhysioPD Platform
Rosa & Co. LLC and the KressWorks Foundation are pleased to announce the completion of the Ewing's sarcoma PhysioMap®. Completion of the PhysioMap is the first milestone in the development of the Ewing's sarcoma PhysioPD Platform.
CHLA researchers receive TRP grant to study new way of combating relapsed ALL
Yong-Mi Kim, MD, PhD, of The Saban Research Institute of Children's Hospital Los Angeles, has been awarded a 3 year translational research program grant from the Leukemia & Lymphoma Society to study a novel approach to eradicating minimal residual disease in patients with acute lymphoblastic leukemia (ALL).
› Verified 8 days ago